PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.42 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,245 | -34.9% | 8,509 | -33.7% | 0.00% | – |
| Q2 2023 | $80,310 | -46.9% | 12,829 | -59.5% | 0.00% | – |
| Q1 2023 | $151,195 | -46.6% | 31,697 | -2.6% | 0.00% | – |
| Q4 2022 | $283,002 | -26.1% | 32,529 | +1.1% | 0.00% | -100.0% |
| Q3 2022 | $383,000 | -18.5% | 32,186 | -2.3% | 0.00% | 0.0% |
| Q2 2022 | $470,000 | +8.3% | 32,960 | +58.1% | 0.00% | 0.0% |
| Q1 2022 | $434,000 | -20.8% | 20,847 | -12.1% | 0.00% | 0.0% |
| Q4 2021 | $548,000 | -21.3% | 23,727 | +1.6% | 0.00% | 0.0% |
| Q3 2021 | $696,000 | -43.6% | 23,362 | -35.4% | 0.00% | -50.0% |
| Q2 2021 | $1,235,000 | +81.6% | 36,166 | +75.0% | 0.00% | +100.0% |
| Q1 2021 | $680,000 | -46.5% | 20,662 | 0.0% | 0.00% | -50.0% |
| Q4 2020 | $1,271,000 | – | 20,662 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Euclidean Capital LLC | 4,179,416 | $257,076,000 | 54.42% |
| INTERWEST VENTURE MANAGEMENT CO | 6,469,911 | $397,964,000 | 49.71% |
| Octagon Capital Advisors LP | 250,000 | $15,378,000 | 5.33% |
| Boxer Capital, LLC | 2,268,236 | $139,519,000 | 4.48% |
| COMMODORE CAPITAL LP | 125,000 | $7,689,000 | 4.18% |
| Orbimed Advisors | 7,330,423 | $450,894,000 | 3.95% |
| Asymmetry Capital Management, L.P. | 96,595 | $5,942,000 | 2.71% |
| Avoro Capital Advisors LLC | 2,350,267 | $130,536,000 | 2.25% |
| RA Capital Management | 1,710,265 | $105,198,000 | 1.47% |
| HighVista Strategies LLC | 22,654 | $1,393,000 | 0.89% |